This suggested that the biological effects of E2 could be enhanced in colon cancer with high ER-β expression, where the carcinogenic functions of Nav1.5 were strengthened, and the prognostic values of Nav1.5 expression were subsequently highlighted in patients with high ER-β expression. The gene discussed is ESR2; the disease is colonic neoplasm.